6 results match your criteria: "General Hospital Munich-Schwabing[Affiliation]"
J Addict Dis
May 2009
General Hospital Munich Schwabing, Munich, Germany.
This cohort study was conducted to identify risk factors for lifetime emergency room treatment due to overdose in injection drug users. Data of 1049 patients on admission for opioid detoxification were analyzed. More than every third injection drug user (34.
View Article and Find Full Text PDFEur Addict Res
November 2005
Addiction Medicine, Clinic 3, General Hospital Munich Schwabing, Munich, Germany.
Background/aim: Injection drug users (IDUs) have a high risk of acquiring an infection with the human immunodeficiency virus (HIV). To improve counseling and prevention, a better understanding of risk factors and predictors for an infection must be gained. This retrospective study has the aim to determine the risk factors for acquisition of HIV infection other than sharing of needles/syringes.
View Article and Find Full Text PDFClin Infect Dis
April 2005
Department of Addiction Medicine, General Hospital Munich-Schwabing, Munich, Germany.
Injection drug users (IDUs) are the largest group of persons infected with hepatitis C virus (HCV), with a prevalence of 50%-90%. The transmission of HCV is not the effect of the drug injected but of sharing contaminated equipment. For the sake of prevention, we have to know which factors are more likely to lead to HCV seroconversion and which particular situations and environments are risk factors for equipment sharing.
View Article and Find Full Text PDFClin Infect Dis
November 2004
Department of Addiction Medicine, General Hospital Munich-Schwabing, Munich, Germany.
We followed-up 18 injection drug users for a mean of 33.8 months (range, 4-55 months) after successful treatment for hepatitis C virus (HCV) infection. Fifteen (83%) of the patients remained HCV RNA-negative, 1 patient was not tested, and 2 patients had test results positive for HCV RNA.
View Article and Find Full Text PDFEur Addict Res
January 2003
Addiction Medicine, General Hospital Munich-Schwabing, Germany.
This retrospective study aims to determine whether there is a difference in the additional consumption of alcohol between addicts treated with methadone or dihydrocodeine (DHC) and untreated addicts injecting heroin. 1685 patients admitted for opioid withdrawal between 1991 and 1997 were reviewed. Cross-reference tables and multiple logistic regression analyses were carried out.
View Article and Find Full Text PDF